E8 media composition: Media contained DMEM/F12, L-ascorbic acid-2-phosphate magnesium (64 mg/l), sodium selenium (14 µg/l), FGF2 (100 µg/l), insulin (19.4 mg/l), NaHCO3 (543 mg/l) and transferrin (10.7 mg/l), TGFβ1(2 µg/l) or NODAL (100 µg/l). Osmolarity of all media was adjusted to 340 mOsm at pH7.4. All the media were stored at 4°C, and were used within 2 weeks of production. L-ascorbic acid-2-phosphate magnesium is the stable form of L-ascorbic acid in cell culture.
Ascorbic Acid
It serves as an essential cofactor for numerous enzymes involved in collagen synthesis, neurotransmitter production, and antioxidant defense.
Ascorbic Acid plays a key role in immune function, wound healing, and the prevention of scurvy.
This powerful antioxidant helps protect cells from oxidative damage and supports overall health and wellbeing.
Researchers utilize a variety of methodologies to study the pharmacokinetics, metabolism, and therapeutic applications of Ascorbic Acid.
PubCompare.ai offers a powerful AI-driven tool to optimize this research by identifying the most reproducible and accruate methods from the literature, preprints, and patents.
Boost your Ascorbic Acid research effciency and accuracy with PubCompare.ai.
Most cited protocols related to «Ascorbic Acid»
E8 media composition: Media contained DMEM/F12, L-ascorbic acid-2-phosphate magnesium (64 mg/l), sodium selenium (14 µg/l), FGF2 (100 µg/l), insulin (19.4 mg/l), NaHCO3 (543 mg/l) and transferrin (10.7 mg/l), TGFβ1(2 µg/l) or NODAL (100 µg/l). Osmolarity of all media was adjusted to 340 mOsm at pH7.4. All the media were stored at 4°C, and were used within 2 weeks of production. L-ascorbic acid-2-phosphate magnesium is the stable form of L-ascorbic acid in cell culture.
Participants in the study were asked twice during pregnancy how often, on average, they had consumed each food item over two periods of several months. The first period covered the time from the last menstruation to the first prenatal visit that occurred between the 10–13 weeks of pregnancy; the second period was the time between the first visit and the second one between weeks 28–32 of gestation. Serving sizes were specified for each food item in the FFQ. The questionnaire had nine possible responses, ranging from ‘never or less than once per month’ to ‘six or more per day’. Additionally, we asked whether study participants followed special diets.
Nutrient values were primarily obtained from the food composition tables of the US Department of Agriculture publications as well as other published sources for Spanish foods and portion sizes [18 ,19 ]. In order to obtain average daily nutrient intakes from diet for each individual, we multiplied the frequency of use for each food by the nutrient composition of the portion/serving size specified on the FFQ and added the results across all foods. For those nutrients often used in supplements during pregnancy such as folate, vitamin C and vitamin B12, the total daily nutrient intake was estimated by adding the average daily intake from supplements and the usual daily nutrient intake from the FFQ. In order to convert folic acid intake from supplements to dietary folate, we used the equivalence of 1 mcg of folate in the diet equals to 0.6 mcg of folic acid from supplements [20 (link)]. We estimated the mean daily consumption for 17 foods and food groups by grouping the intake of specific foods in the FFQ (Table
Most recents protocols related to «Ascorbic Acid»
Example 11
Example 10
Example 10
Steps:
-
- Green Tea Prep Heat 250 mL water to boil
- Steep tea bag 2-3 minutes with occasional
- stir
- remove tea bag and let cool
- Gel Solution
- Prep Use TFF-10-0047 (3.71% silk)
- dilute to 3% silk with water
- dilute to 2% with green tea
- add L-ascorbic acid
- Gelation occurred like standard gel at room
- Gel temperature
- Green/yellow color
- Green Tea scent
- Solution Spec: 2% silk solution
- 65 mL (35 ml of 3.71% silk, 8.3 mL water,
- 21.66 mL green tea)
- 0.43 g L-ascorbic acid
- Green Tea Prep Heat 250 mL water to boil
Example 8
Example 5
-
- Daily oral administration of 5 mg of bioavailable silicic acid in the form of choline-stabilized orthosilicic acid (ch-OSA®), wherein silicic acid is stabilized with choline chloride, for instance in the form of a capsule.
- Daily administration of a tablet containing 200 mg vitamin C, 150 microgram selenium, 10 mg zinc, 1 mg copper.